Bb Biotech AG BB BIOTECH ORD SHS
Bb Biotech AG BB BIOTECH ORD SHS/ CH0038389992 /
0JYO
18/09/2024 17:39:54
|
Chg.
-0.78
|
Volume |
Bid17:40:02 |
Demandez à17:40:02 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
36.77CHF
|
-2.09%
|
21,473 Chiffrre d'affaires: 789,976.28 |
-Bid taille: - |
-Ask la taille: - |
2.04 Mrd.CHF |
5.44% |
- |
Description de l'entreprise
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
Conseil d'administration & Conseil de surveillance
PDG |
- |
Conseil d'administration |
- |
Conseil de surveillance |
Dr. Thomas von Planta, Dr. Clive Meanwell, Laura Hamill, Dr. Pearl Huang, Camilla Soenderby, Prof. Dr. Mads Krogsgaard Thomsen |
Données de l'entreprise
Nom: |
BB Biotech AG |
Adresse: |
Schwertstraße 6,CH-8200 Schaffhausen/Schweiz |
Téléphone: |
+41-52-624-0845 |
Fax: |
- |
Courriel: |
info@bbbiotech.com
|
Internet: |
www.bbbiotech.com |
Industrie: |
Financial |
Secteur: |
Specialty Finance |
Sous-secteur: |
Diversified Financial |
Fin de l'exercice financier: |
31/12 |
Flotte libre: |
97.00% |
IPO date: |
10/12/1997 |
Relations avec les investisseurs
Nom: |
Dr. Silvia Siegfried-Schanz |
Téléphone IR: |
+41-44-267-7266 |
IR-Fax: |
- |
E-mail IR: |
ssc@bellevue.ch
|
Calendrier de l'entreprise
CW 43 | 25/10/2024
Interim Report 3rd Quarter/9 Months
|
Principaux actionnaires
Freefloat |
|
96.47% |
Lazard Asset Management LLC, New York, USA |
|
3.53% |